Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions

Table 2

Compare the clinical efficiency of patients in the two groups ().

Groups		CR	PR	SD	PD	Total treatment efficiency
Control group	50	14 (28.00)	19 (38.00)	10 (20.00)	7 (14.00)	33 (66.00)
Study group	50	20 (40.00)	23 (46.00)	5 (10.00)	2 (4.00)	43 (86.00)
						5.483
						<0.05